Tasca Therapeutics

Tasca Therapeutics is a biotechnology company developing new medicines to treat human diseases. It leverages a unique drug discovery platform identifying novel lipid-binding pockets on proteins to create therapeutics. Its lead program, CP-383, is a first-in-class molecule showing efficacy against multiple cancer types.

Buy Funded Startups lists

Funding Round: Series A

Funding Amount: $52M

Date: 10-Dec-2024

Investors: Regeneron Ventures, Cure Ventures, Invus Group

Markets: Biotechnology, Oncology, Health Care, Wellness

HQ: Boston, Massachusetts, United States

Founded: 2021

Website: https://www.tascatx.com/

LinkedIn:

Twitter:

Instagram: